WIM
ABBV icon

Warwick Investment Management’s AbbVie ABBV Stock Holding History

Warwick Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$537K Buy
2,135
+181
+9% +$38.9K 0.06% 76
2026
Q1 		$425K Sell
1,954
-484
-20% -$107K 0.06% 79
2025
Q4 		$557K Buy
2,438
+35
+1% +$7.97K 0.09% 75
2025
Q3 		$556K Buy
2,403
+321
+15% +$65.4K 0.1% 74
2025
Q2 		$386K Sell
2,082
-237
-10% -$44K 0.08% 75
2025
Q1 		$486K Buy
2,319
+395
+21% +$76.8K 0.1% 68
2024
Q4 		$342K Buy
1,924
+52
+3% +$9.56K 0.07% 69
2024
Q3 		$370K Buy
1,872
+36
+2% +$6.72K 0.09% 59
2024
Q2 		$315K Buy
1,836
+22
+1% +$3.64K 0.07% 75
2024
Q1 		$330K Buy
+1,814
New +$313K 0.08% 70

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Warwick Investment Management's ABBV Position: Q2 2026 in Review

Warwick Investment Management increased its AbbVie (ABBV) stake by 9.3% in Q2 2026, buying an estimated $38.9K and bringing the position to 2,135 shares worth $537K. The position accounts for 0.06% of the portfolio, ranked #76.

Warwick Investment Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $557K in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Warwick Investment Management held 2,135 shares of AbbVie worth $537K as of Q2 2026.
  • Warwick Investment Management bought 181 AbbVie shares in Q2 2026, an estimated $38.9K.
  • AbbVie made up 0.06% of Warwick Investment Management's portfolio in Q2 2026, its #76 holding.
  • Warwick Investment Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • Warwick Investment Management's AbbVie position peaked at $557K in Q4 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Warwick Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.